HRS-4642 trials for Pancreatic cancer

All HRS-4642 trials · All Pancreatic cancer trials

Phase breakdown

Recruiting trials studying HRS-4642 for Pancreatic cancer

• An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer
  NCT06938282 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Exploratory Clinical Study of HRS-4642 Combined With Adebrelimab in the Treatment of Advanced Pancreatic Ductal Adenocarcinoma
  NCT06427239 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients
  NCT06770452 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations

Common questions

How many trials study HRS-4642 for Pancreatic cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.